Results 41 to 50 of about 7,135,840 (226)

Remdesivir for the Treatment of Covid-19 — Final Report

New England Journal of Medicine, 2020
Background Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious.
J. Beigel, Kay M. Tomashek, Lori E. Dodd, Aneesh K. Mehta, Barry S. Zingman, Andre C. Kalil, E. Hohmann, Helen Y. Chu, Anne F. Luetkemeyer, S. Kline, Diego López de Castilla, Robert W. Finberg, K. Dierberg, V. Tapson, L. Hsieh, Thomas F. Patterson, R. Paredes, Daniel A. Sweeney, William R. Short, G. Touloumi, D. Lye, N. Ohmagari, M. Oh, Guillermo M. Ruiz-Palacios, T. Benfield, G. Fätkenheuer, M. Kortepeter, Robert L. Atmar, C. Creech, J. Lundgren, Abdel G. Babiker, S. Pett, J. D. Neaton, Timothy H. Burgess, Tyler Bonnett, Michelle Green, M. Makowski, A. Osinusi, S. Nayak, H. C. Lane   +39 more
semanticscholar   +1 more source

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.

New England Journal of Medicine, 2020
BACKGROUND Progressive respiratory failure is the primary cause of death in the coronavirus disease 2019 (Covid-19) pandemic. Despite widespread interest in the pathophysiology of the disease, relatively little is known about the associated morphologic ...
M. Ackermann, S. Verleden, M. Kuehnel, A. Haverich, T. Welte, F. Laenger, A. Vanstapel, C. Werlein, Helge Stark, A. Tzankov, William Li, V. Li, S. Mentzer, D. Jonigk   +13 more
semanticscholar   +1 more source

Critical appraisal in rapid systematic reviews of COVID-19 studies: implementation of the Quality Criteria Checklist (QCC)

Systematic Reviews, 2023
In this letter, we briefly describe how we selected and implemented the quality criteria checklist (QCC) as a critical appraisal tool in rapid systematic reviews conducted to inform public health advice, guidance and policy during the COVID-19 pandemic ...
Daphne Duval, Nicola Pearce-Smith, Jennifer C. Palmer, Jason Kwasi Sarfo-Annin, Paul Rudd, Rachel Clark   +5 more
doaj   +1 more source

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Thrombosis Research, 2020
Introduction COVID-19 may predispose to both venous and arterial thromboembolism due to excessive inflammation, hypoxia, immobilisation and diffuse intravascular coagulation.
F. Klok, M. Kruip, N. Meer, M. Arbous, D. Gommers, K. Kant, F. Kaptein, J. Paassen, M. Stals, M. Huisman, H. Endeman   +10 more
semanticscholar   +1 more source

The COVID-19 Vaccine Safety Research Center: a cornerstone for strengthening safety evidence for COVID-19 vaccination in the Republic of Korea [PDF]

Osong Public Health and Research Perspectives
The COVID-19 Vaccine Safety Research Committee (CoVaSC) was established in November 2021 to address the growing need for independent, in-depth scientific evidence on adverse events (AEs) following coronavirus disease 2019 (COVID-19) vaccination.
Na-Young Jeong, Hyesook Park, Sanghoon Oh, Seung Eun Jung, Dong-Hyun Kim, Hyoung-Shik Shin, Hee Chul Han, Jong-Koo Lee, Jun Hee Woo, Jaehun Jung, Joongyub Lee, Ju-Young Shin, Sun-Young Jung, Byung-Joo Park, Nam-Kyong Choi   +14 more
doaj   +1 more source

Evaluation of self-administered antigen testing in a college setting

Virology Journal, 2022
Background The objective of our investigation was to better understand barriers to implementation of self-administered antigen screening testing for SARS-CoV-2 at institutions of higher education (IHE).
Sarah C. Tinker, Jessica L. Prince-Guerra, Kelly Vermandere, Jenna Gettings, Cherie Drenzik, Gary Voccio, Tonia Parrott, Jan Drobeniuc, Tonya Hayden, Stephen Briggs, Debbie Heida, Natalie Thornburg, Lisa C. Barrios, John C. Neatherlin, Sabrina Madni, Catherine N. Rasberry, Kenneth D. Swanson, Azaibi Tamin, Jennifer L. Harcourt, Sandra Lester, Lydia Atherton, Margaret A. Honein   +21 more
doaj   +1 more source

COVID-19 Disease and Vaccination: Knowledge, Fears, Perceptions and Feelings of Regret for Not Having Been Vaccinated among Hospitalized Greek Patients Suffering SARS-CoV-2 Infection

Infectious Disease Reports, 2022
Background: The development of vaccines against COVID-19 has greatly altered the natural course of this infection, reducing the disease’s severity and patients’ hospitalization. However, hesitancy against vaccination remains an obstacle in the attempt to
Petros Ioannou, Sotiris Tzalis, Eirini Pasparaki, Despoina Spentzouri, Myrto Konidaki, Ioanna Papakitsou, Nikolaos Spernovasilis, Nikolaos Papanikolaou, George Samonis, Diamantis P. Kofteridis   +9 more
doaj   +1 more source

Intensive diagnostic management of coronavirus disease 2019 (COVID-19) in academic settings in Japan: challenge and future

Inflammation and Regeneration, 2020
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first emerged in Wuhan, China, and has spread globally to most countries. In Japan, the first COVID-19 patient was identified on January 15, 2020.
Tokio Hoshina, Hiroka Aonuma, Manabu Ote, Tatsuya Sakurai, Erisha Saiki, Yuki Kinjo, Kazuhiro Kondo, Masataka Okabe, Hirotaka Kanuka   +8 more
doaj   +1 more source

Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. [PDF]

, 2020
BackgroundAn outbreak of COVID-19 in Iran has spread throughout the country. Identifying the epidemiological characteristics of this disease will help to make appropriate decisions and thus control the epidemic. The aim of this study was characterization
Abbaszadeh, Sepideh, Alimohamadi, Yousef, Alishiri, GholamHossein, Bagheri, Mahdi, Dorostkar, Ruhollah, Ebrahimnia, Mehdi, Farnoosh, Gholamreza, Gouvarchin Ghaleh, Hadi Esmaeili, Heydari, Soleyman, Hosseini Zijoud, Seyed Reza, Izadi, Morteza, Jafari, Nematollah Jonaidi, Jalali Farahani, Alireza, Nikpouraghdam, Mohamad, Qazvini, Ali, Samadinia, Hossein, Sepandi, Mojtaba, Shahriary, Alireza, Taghdir, Maryam, Tat, Mahdi   +19 more
core   +1 more source

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

Journal of Autoimmunity, 2020
Coronavirus disease (COVID-19) is caused by SARS-COV2 and represents the causative agent of a potentially fatal disease that is of great global public health concern. Based on the large number of infected people that were exposed to the wet animal market
H. Rothan, S. Byrareddy
semanticscholar   +1 more source